AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Cell & Advanced Therapies Supply Chain Management Market, 2019-2030: Focus on Technological Solutions - ResearchAndMarkets.com

January 3, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Jan 3, 2020--

The “Cell and Advanced Therapies Supply Chain Management Market, 2019-2030: Focus on Technological Solutions” report has been added to ResearchAndMarkets.com’s offering.

In 2018, around USD 13 billion was invested in this domain, representing a 73% increase in capital investments in this domain, compared to the previous year. It is worth highlighting that, based on an assessment of the current pipeline of cell therapies and the historical clinical success of such products, it is likely that around 10-20 advanced therapies are approved by the US FDA each year, till 2025.

Cell and Advanced Therapies Supply Chain Management Market: Focus on Technological Solutions, 2019-2030 report features an extensive study of the growing supply chain management software solutions market.

The focus of this study is on software systems, including cell orchestration platforms (COP), enterprise manufacturing systems (EMS), inventory management systems (IMS), laboratory information management systems (LIMS), logistics management systems (LMS), patient management systems (PMS), quality management systems (QMS), tracking and tracing software (TTS), and other such platforms that are being used to improve / optimize various supply chain-related processes of cell and advanced therapies.

One of the key objectives of the report was to understand the primary growth drivers and estimate the future size of the supply chain management software solutions market. Based on multiple parameters, such as number of cell and advanced therapies under development, expected pricing, likely adoption rates, and potential cost saving opportunities from different software systems, we have developed informed estimates of the evolution of the market, over the period 2019-2030.

In addition, we have provided the likely distribution of the current and forecasted opportunity across:

Amongst other elements, the report features:

In order to account for the uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios portraying the conservative, base and optimistic tracks of the industry’s evolution.

The opinions and insights presented in this study were influenced by discussions conducted with several stakeholders in this domain. The report features detailed transcripts of interviews held with the following individuals:

Key Topics Covered

1. Preface

2. Executive Summary

3. Introduction

4. Current Market Landscape

5. Company Competitiveness Analysis

6. Core Supply Chain Management Software Solutions: Company Profiles

7. Cell Orchestration Platforms: Emerging Trends and Profiles of Key Players

8. Funding and Investment Analysis

9. Partnerships and Collaborations

10. Platform Utilization Use Cases

11. Value Chain Analysis

12. Stakeholder Needs Analysis

13. Cost Savings Analysis

14. Market Forecast

15. Executive Insights

16. Concluding Remarks

17. Appendix 1: List of Additional Supply Chain Management Software Solutions

18. Appendix 2: Tabulated Data

19. Appendix 3: List of Companies and Organizations

For more information about this report visit https://www.researchandmarkets.com/r/qqw8a

View source version on businesswire.com:https://www.businesswire.com/news/home/20200103005260/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: SUPPLY CHAIN MANAGEMENT RETAIL PHARMACEUTICAL HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 01/03/2020 10:36 AM/DISC: 01/03/2020 10:36 AM

http://www.businesswire.com/news/home/20200103005260/en